Goodwin Procter advised Blueprint Medicines Corporation on the deal while Cooley represented Sixth Street.Blueprint Medicines Corporation (NASDAQ: BPMC) announced its strategic financing collaborations with Sixth Street…
Blueprint Medicines Corporation’s Financing Collaborations with Sixth Street and Royalty Pharma
